Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs

Frontiers in Veterinary Science
Lionel SebbagJonathan P Mochel

Abstract

The study aimed to determine the tear film pharmacokinetics following topical administration of 1% prednisolone acetate-assessing whether two drops would provide a superior kinetic profile compared to one drop-and to determine the fraction of an eye drop that reaches the systemic circulation in dogs. Two separate experiments were conducted in eight healthy Beagle dogs: (i) Instillation of 1 drop (35 μL) or 2 drops (70 μL) of 1% prednisolone acetate ophthalmic suspension in each eye, followed by tear collections with Schirmer strips from 0 to 720 min; (ii) Instillation of 1 or 2 drops of 1% prednisolone acetate in both eyes 4 times daily for 3 days, followed by blood collection 10-15 min after each topical administration on Day 3. Tear and blood samples were analyzed with high performance liquid chromatography to determine the levels of prodrug (prednisolone acetate), active metabolite (prednisolone) and total prednisolone (prednisolonetotal = prodrug + active metabolite). Prednisolone levels represented 10 and 72% of prednisolonetotal concentrations in tears and plasma, respectively, indicating a greater hydrolysis of prodrug in the blood vs. tear compartment. For eyes receiving one or two drops, tear film prednisolonetotal con...Continue Reading

References

Nov 1, 1979·Archives of Ophthalmology·H M Leibowitz, A Kupferman
Jul 1, 1987·European Journal of Drug Metabolism and Pharmacokinetics·O P van BijsterveldB H Nielsen
Feb 1, 1968·Archives of Ophthalmology·P G Burch, C J Migeon
Jan 1, 1982·Survey of Ophthalmology·J W Shell
Feb 1, 1982·Acta Ophthalmologica·L OhmanE D Johansson
May 1, 1993·Survey of Ophthalmology·A Urtti, L Salminen
Sep 1, 1995·The British Journal of Dermatology·K Aalto-Korte, M Turpeinen
Jan 1, 1995·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·D Maurice
Mar 5, 1998·The British Journal of Ophthalmology·N J Van Haeringen
Aug 24, 1999·American Journal of Ophthalmology·O WeijtensJ C van Meurs
Feb 1, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Charles N J McGheeHelen Danesh-Meyer
Apr 28, 2004·The Veterinary Clinics of North America. Small Animal Practice·Bradford J Holmberg, David J Maggs
Apr 21, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Calvin W Roberts, Peter L Nelson
Jul 25, 2007·Acta Ophthalmologica Scandinavica·Hakon H SigurdssonEinar Stefánsson
Jan 15, 2008·Veterinary Ophthalmology·Diane V H Hendrix, Sherry K Cox
Mar 29, 2014·Investigative Ophthalmology & Visual Science·John D SheppardC Stephen Foster
Jul 20, 2016·Pharmaceutical Research·Feng DengArto Urtti
Sep 7, 2016·BMC Ophthalmology·Kaoru Araki-SasakiMasatsugu Nakamura
Dec 21, 2016·Clinical Ophthalmology·Andre FarkouhMartin Czejka
Jan 21, 2017·Pediatrics·Daisuke FukuharaKunimasa Yan
Aug 29, 2017·Veterinary Ophthalmology·Lionel SebbagJonathan P Mochel
May 1, 2018·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Lionel SebbagJonathan P Mochel
Sep 5, 2018·BMC Veterinary Research·Arianne Pontes OriáLionel Sebbag
May 10, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Lionel SebbagJonathan P Mochel
Aug 6, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Lionel SebbagJonathan P Mochel
Jan 11, 2020·Frontiers in Veterinary Science·Lionel SebbagJonathan P Mochel
Jun 12, 2020·Veterinary Ophthalmology·Alex B SigmundDiane V H Hendrix

❮ Previous
Next ❯

Software Mentioned

Xcalibur
Excel
SigmaPlot
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
M J GöbbelsM Spitznas
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
M J GöbbelsM Spitznas
© 2021 Meta ULC. All rights reserved